Biotech
02 capsules00 articles
Subscribe to Biotech- BiotechEthicsPolicy
HuidaGene discloses a CRISPR trial death twelve months late
HuidaGene Therapeutics waited a year to disclose that a boy in the high-dose cohort of its Duchenne gene-editing trial died in August 2025.
02 - BiotechPolicy
Intellia ties its worst liver signals to a single HLA allele
A genomic analysis of more than 600 samples found the highest liver enzyme elevations in Intellia in vivo CRISPR trials clustered in carriers of one HLA allele.
02